Literature DB >> 11039343

Correlation of myo-inositol levels and grading of cerebral astrocytomas.

M Castillo1, J K Smith, L Kwock.   

Abstract

BACKGROUND AND
PURPOSE: In a limited number of patients, the level of myo-inositol (MI), as seen by proton magnetic resonance spectroscopy (HMRS), has been shown to differ for gliomas of different histologic grades. We sought to determine if MI levels correlate with cerebral astrocytoma grade.
METHODS: Five control subjects, 14 patients with low-grade astrocytoma, 10 patients with anaplastic astrocytoma, and 10 patients with glioblastoma multiforme (GBM) underwent single-volume HMRS with an echo time of 20 ms. Twenty-five patients had received surgery, chemotherapy, and/or radiation therapy previously. Using the curve-fitting program supplied by the manufacturer, peak areas for n-acetyl aspartate (NAA), choline (Cho), and MI were normalized with respect to the peak area of creatine (Cr). Ratios for MI/Cr, Cho/Cr, and NAA/Cr were obtained for each lesion and retrospectively compared with the histologic grade of the lesion.
RESULTS: Levels of MI/Cr were higher (0.82 +/- 0.25) in patients with low-grade astrocytoma, intermediate (0.49 +/- 0.07) in control subjects, and lower in patients with anaplastic astrocytoma (0.33 +/- 0.16) and GBM (0.15 +/- 0.12).
CONCLUSION: Our study shows a trend toward lower MI levels in the presence of anaplastic astrocytomas and GBMs compared with those of low-grade astrocytomas. MI levels may have implications in the grading of cerebral astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039343      PMCID: PMC8174883     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.

Authors:  L L Cheng; I W Chang; D N Louis; R G Gonzalez
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

Review 2.  Proton MR spectroscopy of common brain tumors.

Authors:  M Castillo; L Kwock
Journal:  Neuroimaging Clin N Am       Date:  1998-11       Impact factor: 2.264

3.  Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children.

Authors:  Z Wang; R A Zimmerman; R Sauter
Journal:  AJR Am J Roentgenol       Date:  1996-07       Impact factor: 3.959

Review 4.  Signalling through the lipid products of phosphoinositide-3-OH kinase.

Authors:  A Toker; L C Cantley
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

5.  Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

Authors:  J H Uhm; N P Dooley; J G Villemure; V W Yong
Journal:  Clin Exp Metastasis       Date:  1996-10       Impact factor: 5.150

6.  Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors.

Authors:  J F Norfray; T Tomita; S E Byrd; B D Ross; P A Berger; R S Miller
Journal:  AJR Am J Roentgenol       Date:  1999-07       Impact factor: 3.959

7.  1H NMR detection of cerebral myo-inositol.

Authors:  S Cerdàn; R Parrilla; J Santoro; M Rico
Journal:  FEBS Lett       Date:  1985-07-22       Impact factor: 4.124

8.  Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate.

Authors:  T F Franke; D R Kaplan; L C Cantley; A Toker
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

9.  Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies.

Authors:  R J Maxwell; I Martínez-Pérez; S Cerdán; M E Cabañas; C Arús; A Moreno; A Capdevila; E Ferrer; F Bartomeus; A Aparicio; G Conesa; J M Roda; F Carceller; J M Pascual; S L Howells; R Mazucco; J R Griffiths
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

10.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.

Authors:  B L Miller; R A Moats; T Shonk; T Ernst; S Woolley; B D Ross
Journal:  Radiology       Date:  1993-05       Impact factor: 11.105

  10 in total
  90 in total

1.  Glial neoplasms without elevated choline-creatine ratios.

Authors:  Brian C Bowen
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels.

Authors:  Ana Londoño; Mauricio Castillo; Diane Armao; Lester Kwock; Kinuko Suzuki
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

4.  Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Authors:  Radhika Srinivasan; Joanna J Phillips; Scott R Vandenberg; Mei-Yin C Polley; Gabriela Bourne; Alvin Au; Andrea Pirzkall; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-07-20       Impact factor: 12.300

5.  Early prediction of response to Vorinostat in an orthotopic rat glioma model.

Authors:  Li Wei; Samuel Hong; Younghyoun Yoon; Scott N Hwang; Jaekeun C Park; Zhaobin Zhang; Jeffrey J Olson; Xiaoping P Hu; Hyunsuk Shim
Journal:  NMR Biomed       Date:  2012-02-02       Impact factor: 4.044

6.  Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade.

Authors:  Neslin Sahin; Elias R Melhem; Sumei Wang; Jaroslaw Krejza; Harish Poptani; Sanjeev Chawla; Gaurav Verma
Journal:  Neuroradiol J       Date:  2013-11-07

7.  MRS as an Aid to Diagnose Malignant Transformation in Low-Grade Gliomas with Increasing Contrast Enhancement.

Authors:  C H Toh; M Castillo; K-C Wei; P-Y Chen
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

8.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

9.  Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.

Authors:  Yan Li; Radhika Srinivasan; Helene Ratiney; Ying Lu; Susan M Chang; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

10.  Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels.

Authors:  Yan Li; Peder Larson; Albert P Chen; Janine M Lupo; Eugene Ozhinsky; Douglas Kelley; Susan M Chang; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2014-06-17       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.